Vitura Health Ltd - Asset Resilience Ratio

Latest as of June 2024: 16.76%

Vitura Health Ltd (VIT) has an Asset Resilience Ratio of 16.76% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check VIT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$11.94 Million

≈ $8.45 Million USD Cash + Short-term Investments

Total Assets

AU$71.28 Million

≈ $50.44 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how Vitura Health Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Vitura Health Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Vitura Health Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see VIT market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$11.94 Million	16.76%
Total Liquid Assets	AU$11.94 Million	16.76%

Asset Resilience Insights

Good Liquidity Position: Vitura Health Ltd maintains a healthy 16.76% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Vitura Health Ltd Industry Peers by Asset Resilience Ratio

Compare Vitura Health Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Vitura Health Ltd (2024–2024)

The table below shows the annual Asset Resilience Ratio data for Vitura Health Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	16.76%	AU$11.94 Million ≈ $8.45 Million	AU$71.28 Million ≈ $50.44 Million	--

pp = percentage points

About Vitura Health Ltd

AU:VIT Australia Drug Manufacturers - Specialty & Generic

Market Cap

$14.07 Million

AU$19.88 Million AUD

Market Cap Rank

#26180 Global

#1197 in Australia

Share Price

AU$0.03

Change (1 day)

+0.00%

52-Week Range

AU$0.03 - AU$0.07

All Time High

AU$0.96